Wellington Management Group
ANRO icon

Wellington Management Group’s Alto Neuroscience ANRO Stock Holding History

Wellington Management Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Sell
59,799
-9,217
-13% -$171K ﹤0.01% 1620
2025
Q4 		$1.23M Buy
+69,016
New +$869K ﹤0.01% 1683
2025
Q1 		– Sell
-77,146
Closed -$326K – 2067
2024
Q4 		$326K Buy
77,146
+16,510
+27% +$103K ﹤0.01% 1869
2024
Q3 		$694K Buy
+60,636
New +$742K ﹤0.01% 1770

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group's ANRO Position: Q1 2026 in Review

Wellington Management Group reduced its Alto Neuroscience (ANRO) stake by 13% in Q1 2026, selling an estimated $171K and leaving 59,799 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Wellington Management Group first reported a position in ANRO in Q3 2024 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Wellington Management Group held 59,799 shares of Alto Neuroscience worth $1.34M as of Q1 2026.
  • Wellington Management Group sold 9,217 Alto Neuroscience shares in Q1 2026, an estimated $171K.
  • Alto Neuroscience made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1620 holding.
  • Wellington Management Group first reported a position in Alto Neuroscience in Q3 2024 and has held it in 4 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.